Results 41 to 50 of about 174,736 (301)

Impact of gout on the risk of atrial fibrillation [PDF]

, 2016
OBJECTIVES: To examine the risk of atrial fibrillation (AF) at the time of first diagnosis of gout compared with matched controls and to follow incident gout patients and their matched controls after diagnosis to compare their subsequent risk of AF ...
Chang-Fu Kuo, Christian Mallen, De Vera, Korantzopoulos, Matthew J. Grainge, Michael Doherty, Weiya Zhang, Zhao   +7 more
core   +1 more source

Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration

Arthritis Care &Research, EarlyView.
Objective Though used frequently to treat flare, risk of long‐term opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed long‐term opioids over time.
Lindsay N. Helget, Bryant R. England, Punyasha Roul, Harlan Sayles, Tuhina Neogi, James R. O'Dell, Joshua F. Baker, Ted R. Mikuls   +7 more
wiley   +1 more source

Risk factors for bone erosion in male patients with gout [PDF]

精准医学杂志
Objective To investigate the risk factors associated with bone erosion in male patients with gout. Methods A total of 297 male patients with gout who presented for their initial visit to the Gout Clinical Medical Center of the Affiliated Hospital of ...
HUO Fei, AI Xiaobo, REN Wei, HAN Lin, LI Runze
doaj   +1 more source

Patients Prescribed Anakinra for Acute Gout Have Baseline Increased Burden of Hyperuricemia, Tophi, and Comorbidities, and Ultimate All-Cause Mortality. [PDF]

, 2019
Objective:The interleukin-1 (IL-1) receptor antagonist anakinra is an effective, off-label option in acute gout flares, when conventional therapy options are narrowed.
Pedersen, Brian, Sharma, Ena, Terkeltaub, Robert   +2 more
core  

Comorbidities in patients with gout prior to and following diagnosis: case-control study [PDF]

, 2016
OBJECTIVES: To determine the burden of comorbidities in patients with gout at diagnosis and the risk of developing new comorbidities post diagnosis. METHODS: There were 39 111 patients with incident gout and 39 111 matched controls identified from ...
Ab. Usbott, Abbott, Ames, Annemans, Bhole, Boffetta, Bowman, Cea Soriano, Chang-Fu Kuo, Charlson, Chen, Chhana, Choi, Choi, Choi, Christian Mallen, Clarson, Creighton, De Vera, Deyo, Durward, Erickson, Feinstein, Herrett, Jick, Jick, Jordan, Kanellis, Kellgren, Khan, Khan, Khanna, Khokhar, Kramer, Kramer, Krishnan, Krishnan, Kuo, Kuo, Kuo, Kuo, Kuo, Kuo, Kuo, Kuo, Kuzell, Liu, Lottmann, Mariani, Matthew J Grainge, McAdams-Demarco, Meier, Merola, Michael Doherty, Obermayr, Obermayr, Pascual, Puig, Rathmann, Reynolds, Rho, Richette, Richette, Roddy, Rodriguez, Seminog, Shimizu, Terkeltaub, Vuorinen-Markkola, Wallace, Walley, Weiya Zhang, Yu, Yu, Yu, Zang, Zhang, Zhang, Zhu   +78 more
core   +2 more sources

Cost‐Effectiveness of Low‐Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start‐Low Go‐Slow” Approach for Gout: Evidence From a Noninferiority Randomized Double‐Blind Placebo‐Controlled Trial

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko, Ross Wilson, Nicola Dalbeth, J. Haxby Abbott, Lisa Stamp   +4 more
wiley   +1 more source

Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects

Molecular Genetics & Genomic Medicine, 2019
Background To identify potential causative mutations in SLC2A9 and SLC22A12 that lead to hypouricemia or hyperuricemia (HUA). Methods Targeted resequencing of whole exon regions of SLC2A9 and SLC22A12 was performed in three cohorts of 31 hypouricemia ...
Zhaowei Zhou, Ke Wang, Juan Zhou, Can Wang, Xinde Li, Lingling Cui, Lin Han, Zhen Liu, Wei Ren, Xuefeng Wang, Keke Zhang, Zhiqiang Li, Dun Pan, Changgui Li, Yongyong Shi   +14 more
doaj   +1 more source

The Role of Advanced Imaging in Gout Management

Frontiers in Immunology, 2022
Gout is a common form of inflammatory arthritis where urate crystals deposit in joints and surrounding tissues. With the high prevalence of gout, the standardized and effective treatment of gout is very important, but the long-term treatment effect of ...
Shuangshuang Li, Guanhua Xu, Junyu Liang, Liyan Wan, Heng Cao, Jin Lin   +5 more
doaj   +1 more source

Non-Existence of Time-Periodic Solutions of the Dirac Equation in a Reissner-Nordstrom Black Hole Background [PDF]

, 2000
It is shown analytically that the Dirac equation has no normalizable, time-periodic solutions in a Reissner-Nordstrom black hole background; in particular, there are no static solutions of the Dirac equation in such a background field.
Choptuik M. W., Christodoulou D., Felix Finster, Finster F., Finster F., Finster F., Joel Smoller, Nicolas J.-P., Nicolas J.-P., Shing-Tung Yau, Smoller J.   +10 more
core   +2 more sources

Perceptions About Asymptomatic Hyperuricemia and Views About Urate‐Lowering Therapy in People With Asymptomatic Hyperuricemia

Arthritis Care &Research, EarlyView.
Objective Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate‐lowering therapy in people with asymptomatic hyperuricemia. Methods Participants in a multinational study of
Nicola Dalbeth, Sarah Stewart, Gregory D. Gamble, Borislav Mihov, Lisa K. Stamp, Janine Haslett, William J. Taylor, Tony R. Merriman, Adwoa Dansoa Tabi‐Amponsah, Anne Horne, Tuhina Neogi, Tristan Pascart, Mariano Andrés, Maria‐Luisa Peral‐Garrido, Eleonora Norkuviene, Janitzia Vazquez‐Mellado, Till Uhlig, Mingshu Sun, Changgui Li, Keith J. Petrie   +19 more
wiley   +1 more source